Navigation Links
uBiome to Sponsor First Annual Microbiome Conference at 2019 World Economic Forum Annual Meeting in Davos-Kloster, Switzerland
Date:1/4/2019

uBiome, the leader in microbial genomics, will sponsor the world’s first Microbiome Conference at the World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following their selection as a 2018 Technology Pioneer. The conference is invitation-only.

The World Economic Forum Annual Meeting brings together leaders of global society–the heads and members of more than 100 governments, top executives of the 1,000 foremost global companies, leaders of international organizations, and prominent thought leaders–to define priorities and shape global, industry, and regional agendas.

uBiome was chosen to join the Technology Pioneer community in 2018, composed of early-stage companies from around the world that are involved in the design, development, and deployment of new technologies and innovations, and are poised to have a significant impact on business and society. Previous recipients include Google, Foundation Medicine, Airbnb, Kickstarter, Spotify, and Twitter.

The microbiome is believed to have a profound effect on human health, including synthesizing vitamins, metabolizing nutrients, impacting immune response, and interacting with our hormones.

Given that recent research suggests microbes influence body systems and various health conditions, understanding and further manipulating these interactions may allow for better management and treatment of conditions.

“The microbiome is one of the most significant scientific discoveries of our age, regarded as a new organ of the human body, and it is proposed to revolutionize the future of healthcare. As such, the microbiome is of eminent importance to global thought-leaders,” Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. “uBiome is honored to contribute cutting-edge insights to initiatives and world-critical discussions at the Annual Meeting by sponsoring the first Microbiome Conference at WEF.”

To learn more about uBiome’s accomplishments, please visit https://ubiome.com/news-press/.

About uBiome
Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.

uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; SmartFlu™, the world’s first sequencing-based clinical respiratory test, which identifies more than 20 clinically relevant targets for viruses and bacteria associated with the flu and common cold; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.

uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.

Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.

Read the full story at https://www.prweb.com/releases/ubiome_to_sponsor_first_annual_microbiome_conference_at_2019_world_economic_forum_annual_meeting_in_davos_kloster_switzerland/prweb15992244.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. uBiome Appoints Dr. Pablo Valenzuela, PhD, World-Renowned Biochemist and Entrepreneur, to its Scientific Advisory Board
2. uBiome Appoints Dr. Philip Bourne, PhD, Director of the Data Science Institute at the University of Virginia, to its Scientific Advisory Board
3. uBiome Appoints Dr. Isabel Moreno-Indias, PhD, Senior Researcher of Cellular and Molecular Endocrinology, to its Scientific Advisory Board
4. uBiome Grant Will Enable UCSF Scientist to Explore ‘Spit Test’ to Predict Blood Infections in Young Bone Marrow Transplant Patients
5. uBiome and Jackson Laboratory for Genomic Medicine to Study Pathogen Transmission in Geriatric Communities
6. uBiome Publishes Peer-Reviewed Scientific Paper in PLOS ONE on First Version of Technology for Gut Health Screening Test
7. Study on How Marital Stress May Affect the Gut Microbiome with uBiome Microbiome Impact Grant
8. uBiome Announces SmartBiome ID™: Sample-Agnostic Pathogen Detection Platform
9. Boston Children’s Hospital and uBiome to Investigate Premature Births
10. Stanford Medicine and uBiome Investigate Relationship Between Gut Bacteria and Diabetes
11. Dutch Journal of Medical Microbiology Publishes uBiome Science Editor’s Most Recent Microbiome Paper
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life ... cells in blood, has been named as a partner in Medigen Biotech’s upcoming ... cell therapies for cancer treatment, will use CellMax Life’s circulating tumor cell platform ...
(Date:12/19/2018)... ... 19, 2018 , ... R3 Stem Cell is now offering ... in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile dysfunction procedures ... aesthetics, having the training from expert, Board Certified providers is critical to instilling ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, the leading ... industry, unveiled a completely redesigned website at http://www.usdm.com . The site offers ... their valued clients and business partners. , The website has a revamped ...
(Date:12/13/2018)... ... December 11, 2018 , ... Researchers at ... use to quickly detect Clostridium difficile (C. diff), a dangerous and sometimes fatal ... device that can be used onsite in doctor’s offices and nursing homes, providing ...
Breaking Biology Technology:
(Date:12/19/2018)... CITY, N.Y. (PRWEB) , ... December 19, 2018 , ... ... the most innovative products in healthcare for 2018. , PM360 is featuring the ... most innovative products and services offered to the pharmaceutical and medical device industries. ...
(Date:12/18/2018)... ... 18, 2018 , ... Nativis, Inc. , a clinical ... today announced the publication of an early feasibility study in CNS Oncology suggesting ... The publication of the study, An Early Feasibility Study of the Nativis Voyager® ...
(Date:12/13/2018)... ... 13, 2018 , ... Study Protocol Summary of QC Procedure , 1 – ... assessment performed at the site., 3 - Three photos captured with Apple iPad and ... BOX., 5 - Photos moved to eAdjudication® and submitted to Reviewers., 6 - ...
Breaking Biology News(10 mins):